Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Rafael Holdings Inc (RFL)

Rafael Holdings Inc (RFL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,626
  • Shares Outstanding, K 24,913
  • Annual Sales, $ 640 K
  • Annual Income, $ -34,410 K
  • EBIT $ -104 M
  • EBITDA $ -104 M
  • 60-Month Beta 1.01
  • Price/Sales 54.36
  • Price/Cash Flow N/A
  • Price/Book 0.48

Options Overview Details

View History
  • Implied Volatility 129.15% ( -559.08%)
  • Historical Volatility 69.29%
  • IV Percentile 27%
  • IV Rank 15.58%
  • IV High 688.23% on 05/15/25
  • IV Low 25.95% on 09/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 216
  • Put/Call OI Ratio 6.93
  • Today's Open Interest 1,983
  • Open Int (30-Day) 1,313

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3200 +8.33%
on 05/09/25
1.7400 -17.82%
on 04/28/25
-0.1700 (-10.63%)
since 04/16/25
3-Month
1.3200 +8.33%
on 05/09/25
2.1200 -32.55%
on 03/25/25
-0.6500 (-31.25%)
since 02/14/25
52-Week
1.2900 +10.85%
on 07/12/24
2.5000 -42.80%
on 10/14/24
-0.1600 (-10.06%)
since 05/16/24

Most Recent Stories

More News
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

RFL : 1.4300 (unch)
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

RFL : 1.4300 (unch)
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role

RFL : 1.4300 (unch)
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals

CYTH : 0.7206 (+1.39%)
RFL : 1.4300 (unch)
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results

CYTH : 0.7206 (+1.39%)
RFL : 1.4300 (unch)
Rafael Holdings, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Updates on Planned Merger with Cyclo Therapeutics

Rafael Holdings reports Q1 fiscal 2025 results, anticipates merger with Cyclo Therapeutics, and focuses on Trappsol® Cyclo™ development.Quiver AI SummaryRafael Holdings, Inc. reported its financial...

RFL : 1.4300 (unch)
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

RFL : 1.4300 (unch)
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

RFL : 1.4300 (unch)
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation...

CYTH : 0.7206 (+1.39%)
RFL : 1.4300 (unch)
Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D.

CRANBURY, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.4300 (unch)

Business Summary

Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.

See More

Key Turning Points

3rd Resistance Point 1.5299
2nd Resistance Point 1.4899
1st Resistance Point 1.4600
Last Price 1.4300
1st Support Level 1.3901
2nd Support Level 1.3501
3rd Support Level 1.3202

See More

52-Week High 2.5000
Fibonacci 61.8% 2.0378
Fibonacci 50% 1.8950
Fibonacci 38.2% 1.7522
Last Price 1.4300
52-Week Low 1.2900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar